IBDEI1ET ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22547,1,3,0)
 ;;=3^Coccidioidomycosis,Unspec
 ;;^UTILITY(U,$J,358.3,22547,1,4,0)
 ;;=4^B38.9
 ;;^UTILITY(U,$J,358.3,22547,2)
 ;;=^5000631
 ;;^UTILITY(U,$J,358.3,22548,0)
 ;;=B45.8^^102^1142^20
 ;;^UTILITY(U,$J,358.3,22548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22548,1,3,0)
 ;;=3^Cryptococcosis NEC
 ;;^UTILITY(U,$J,358.3,22548,1,4,0)
 ;;=4^B45.8
 ;;^UTILITY(U,$J,358.3,22548,2)
 ;;=^5000674
 ;;^UTILITY(U,$J,358.3,22549,0)
 ;;=B45.1^^102^1142^21
 ;;^UTILITY(U,$J,358.3,22549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22549,1,3,0)
 ;;=3^Cryptococcosis,Meningitis/CNS
 ;;^UTILITY(U,$J,358.3,22549,1,4,0)
 ;;=4^B45.1
 ;;^UTILITY(U,$J,358.3,22549,2)
 ;;=^5000670
 ;;^UTILITY(U,$J,358.3,22550,0)
 ;;=A07.2^^102^1142^22
 ;;^UTILITY(U,$J,358.3,22550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22550,1,3,0)
 ;;=3^Cryptosporidiosis
 ;;^UTILITY(U,$J,358.3,22550,1,4,0)
 ;;=4^A07.2
 ;;^UTILITY(U,$J,358.3,22550,2)
 ;;=^29629
 ;;^UTILITY(U,$J,358.3,22551,0)
 ;;=N30.90^^102^1142^23
 ;;^UTILITY(U,$J,358.3,22551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22551,1,3,0)
 ;;=3^Cystitis
 ;;^UTILITY(U,$J,358.3,22551,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,22551,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,22552,0)
 ;;=B25.9^^102^1142^24
 ;;^UTILITY(U,$J,358.3,22552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22552,1,3,0)
 ;;=3^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,22552,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,22552,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,22553,0)
 ;;=B35.9^^102^1142^25
 ;;^UTILITY(U,$J,358.3,22553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22553,1,3,0)
 ;;=3^Dermatophytosis
 ;;^UTILITY(U,$J,358.3,22553,1,4,0)
 ;;=4^B35.9
 ;;^UTILITY(U,$J,358.3,22553,2)
 ;;=^5000607
 ;;^UTILITY(U,$J,358.3,22554,0)
 ;;=E11.9^^102^1142^26
 ;;^UTILITY(U,$J,358.3,22554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22554,1,3,0)
 ;;=3^Diabetes,Type II,Controlled
 ;;^UTILITY(U,$J,358.3,22554,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,22554,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,22555,0)
 ;;=E11.65^^102^1142^27
 ;;^UTILITY(U,$J,358.3,22555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22555,1,3,0)
 ;;=3^Diabetes,Type II,Uncontrolled
 ;;^UTILITY(U,$J,358.3,22555,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,22555,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,22556,0)
 ;;=R19.7^^102^1142^28
 ;;^UTILITY(U,$J,358.3,22556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22556,1,3,0)
 ;;=3^Diarrhea
 ;;^UTILITY(U,$J,358.3,22556,1,4,0)
 ;;=4^R19.7
 ;;^UTILITY(U,$J,358.3,22556,2)
 ;;=^5019276
 ;;^UTILITY(U,$J,358.3,22557,0)
 ;;=R74.0^^102^1142^29
 ;;^UTILITY(U,$J,358.3,22557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22557,1,3,0)
 ;;=3^Elevation of Transaminases
 ;;^UTILITY(U,$J,358.3,22557,1,4,0)
 ;;=4^R74.0
 ;;^UTILITY(U,$J,358.3,22557,2)
 ;;=^5019565
 ;;^UTILITY(U,$J,358.3,22558,0)
 ;;=N52.9^^102^1142^31
 ;;^UTILITY(U,$J,358.3,22558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22558,1,3,0)
 ;;=3^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,22558,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,22558,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,22559,0)
 ;;=K20.9^^102^1142^32
 ;;^UTILITY(U,$J,358.3,22559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22559,1,3,0)
 ;;=3^Esophagitis,Unspec
 ;;^UTILITY(U,$J,358.3,22559,1,4,0)
 ;;=4^K20.9
 ;;^UTILITY(U,$J,358.3,22559,2)
 ;;=^295809
 ;;^UTILITY(U,$J,358.3,22560,0)
 ;;=R53.83^^102^1142^33
